Douglas L Orsi
9PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Aug 18, 2025
Discovery of an orally bioavailable, CNS active pan-mutant RET kinase heterobifunctional degrader.Douglas L Orsi, Kiel E Lazarski, Reina Improgo
|Aug 06, 2024
Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M5 Muscarinic Acetylcholine Receptor.Jinming Li, Douglas L Orsi, Julie L Engers
|Dec 21, 2022
Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069".Douglas L Orsi, Elisabeth Pook, Nico Bräuer
|Aug 01, 2022
Cu(II)-Catalyzed Unsymmetrical Dioxidation of gem-Difluoroalkenes to Generate α,α-Difluorinated-α-phenoxyketones.Suvajit Koley, Kaylee T Cayton, Gisela A González-Montiel
|Apr 13, 2022
Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder.Aaron T Garrison, Douglas L Orsi, Rory A Capstick
|Feb 23, 2021
Correction to "Acid-Catalyzed Hydrothiolation of gem-Difluorostyrenes to Access α,α-Difluoroalkylthioethers".Jacob P Sorrentino, Douglas L Orsi, Ryan A Altman
Pageof 2
Frequent Collaborators
5 joint publications
Ryan A Altman
3 joint publications
Jacob P Sorrentino
2 joint publications
Craig W Lindsley
2 joint publications
Changho Han
1 joint publications
Justin T Douglas
1 joint publications
Laura B Teal
1 joint publications
Daniel J Foster
1 joint publications
Suvajit Koley
1 joint publications
M Ramu Yadav
1 joint publications
Andrew J Intelli
